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Abstract 
Mesenchymal stromal cells (MSC) are dif-
ferentiation competent cells and may gener-
ate,  among  others,  mature  osteoblasts  or
chondrocytes in vitro and in vivo. Laminin-5
and type I collagen are important components
of the extracellular matrix. They are involved
in a variety of cellular and extracellular activi-
ties including cell attachment and osteogenic
differentiation of MSC. MSC were isolated and
expanded using media conforming good medi-
cal  practice  (GMP)-regulations  for  medical
products. Cells were characterized according
to the defined minimal criteria for multipotent
MSC. MTT- and BrdU-assays were performed
to  evaluate  protein-dependent  (laminin-5,
laminin-1, type I collagen) metabolic activity
and  proliferation  of  MSC.  MSC-attachment
assays were performed using protein-coated
culture  plates.  Osteogenic  differentiation  of
MSC  was  measured  by  protein-dependant
mineralization and expression of osteogenic
marker  genes  (osteopontin,  alkaline
phophatase, Runx2) after three, seven and 28
days  of  differentiation.  Marker  genes  were
identified  using  quantitative  reverse-tran-
scription  polymerase  chain  reaction.
Expansion of MSC in GMP-conforming media
yielded vital cells meeting all minimal criteria
for MSC. Attachment assay revealed a favor-
able binding of MSC to laminin-5 and type I
collagen  at  a  protein  concentration  of  1-5
fmol/mL. Compared to plastic, osteogenic dif-
ferentiation  was  significantly  increased  by
laminin-5 after 28 days of culture (P<0.04).
No significant differences in gene expression
patterns  were  observed.  We  conclude  that
laminin-5 and type I collagen promote attach-
ment,  but  laminin-1  and  laminin-5  promote
osteogenic differentiation of MSC. This may
influence future clinical applications.
Introduction
Mesenchymal stem cells (MSC) were origi-
nally described by Friedstein et al. in 1966 as
clonal, plastic adherent cells with a high prolif-
eration rate and the potential of differentiation
into  cells  of  mesodermal  origins  including
osteocytes,  chondrocytes  and  adipocytes  in
vitro.1 According to the consensus in nomen-
clature, these cells were termed multipotent
mesenchymal stromal cells.2,3 For both cell pop-
ulations, the acronym MSC may be used.3 The
ability of MSC to differentiate into numerous
tissues reveals promising potential for tissue
engineering, cell therapies and future clinical
applications.
Cell differentiation is regulated by soluble
factors (e.g. TGF-ʲ, BMPs, insulin-like growth
factor, dexamethasone) and the extracellular
matrix (ECM) surrounding the cells in which
both  mechanisms  are  closely  connected.
Several ECM-proteins, such as type I collagen,
laminin-5, and vitronectin, have been identi-
fied as regulators of MSC-adhesion and induc-
ers  of  osteogenic  differentiation  in  vitro.4-10
Fetal calf serum (FCS) is widely used for cell
culture,4-7 but in the context of possible further
clinical  applications  animal  serum  does  not
meet  the  European  Good  Manufacturing
Practice (GMP) regulations for medical prod-
ucts.  The  risk  of  immunological  reactions,
prion  transmission  and  potential  metabolic
changes  in  cultured  cells  must  be  consid-
ered.11-13 Therefore, we use a GMP-compatible
protocol employing MSC-expansion and differ-
entiation media in which FCS is replaced by
human  plasma  and  platelet  extract  as
described  previously.13-15 In  this  study,  we
examined the effects of laminin-5, laminin-1
and type I collagen on MSC, their in vitro pro-
liferation, adhesion to these matrix proteins
and their osteogenic differentiation. 
Materials and Methods
Isolation, expansion and cell
culture of human bone marrow
mesenchymal stromal cells
Bone marrow samples were obtained from
14 patients (age 45 to 72 years) undergoing
total hip arthroplasty (femur shafts) or pelvic
osteotomy at the Department of Orthopaedic
Surgery at UKT (Tübingen, Germany) or the
BGU  Trauma  Center  (Tübingen,  Germany),
after written consent was given. This study has
been approved by the local ethics committee of
the University of Tübingen (Germany). 
Bone marrow was washed with phosphate-
buffered  saline  (PBS,  BioWhittaker)  and  a
lipid layer was removed after centrifugation.
MSC were isolated using Ficoll density-gradi-
ent  centrifugation  and  mononucleated  cells
were collected in the interphase (Ficoll-Paque
Premium, GE Healthcare, Munich, Germany).
The cells were washed with PBS, centrifuged
and  seeded  at  a  density  of  1ﾥ106 to  1ﾥ107
cells/cm2 in  75  cm2 cell  culture  falcons  (BD
Biosciences, Heidelberg, Germany) in expan-
sion  medium  containing  low-glucose
Dulbecco’s  modified  Eagle  medium  (DMEM,
Lonza, Basel, Switzerland) supplemented with
5%  human  fresh  frozen  plasma  (FFP),  5%
platelet concentrate (108 platelets/mL medium,
Blood Donor Center, University of Tu ￿bingen), 2
mM L-glutamine (Lonza, Basel, Switzerland),
1000  IU  heparin  sodium  (Roth,  Karlsruhe,
Germany),  100  U/mL  penicillin  G,  and  100
mg/mL  streptomycin  (Gibco,  Invitrogen,
Karlsruhe, Germany) at 37°C in a humidified
atmosphere with 95% air and 5% CO2. After 24
h  of  incubation,  non-adherent  cells  were
removed and adherent cells were detached by
trypsin-EDTA, passaged and expanded in fresh
cell  culture  medium.  The  medium  was
changed  at  least  twice  a  week.  Cells  were
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detached  with  Accutase®  (PAA,  Pasching,
Austria)  and  passaged  when  reaching  80%
confluence. They were seeded at a density of
1.5x105 cell/flask. Cells were used for experi-
ments after three passages. 
Characterization of mesenchymal
stromal cells
The MSC were characterized by the defined
minimal criteria for multipotent mesenchymal
stromal  cells,  such  as  adherence  to  plastic,
expression  or  lack  of  expression  of  defined
cell-surface antigens analyzed by flow cytome-
try  (CD11b-,  CD14-,  CD34-,  CD45-,  CD73+,
CD90+,  and  CD105+)  and  the  ability  for  in
vitro differentiation into osteoblasts, adipocyts
and chondroblasts.16
Attachment assays
For  cell  attachment  assays,  laminin-1
(Sigma), laminin-5 (Abcam, Cambridge, MA,
USA)  and  type  I  collagen  (BD  Bioscience)
were  solved  in  PBS  in  concentrations  of  1
fmol/mL,  10  fmol/mL,  100  fmol/mL  or  500
fmol/mL.  Tissue  culture  plates  were  coated
with  1  mL  aliquots  of  the  protein  solutions
(about  1  mm2 of  plate  area).  BSA  (bovine
serum albumin) served as control. These spots
were  air-dried  and  the  plates  were  blocked
with 200 mL 1% BSA/PBS (Sigma) for 1 h and
washed with PBS prior to the assay. Then 200
mL of MSC suspension in PBS were loaded on
the spot for attachment for 15 min, washed
with PBS, and adherent cells were microscopi-
cally  photographed  (Zeiss  Anxiovert  13  S,
Jena, Nikon camera). 
MTT cell proliferation assay
For measurement of protein-dependant dif-
ferences in metabolic activity of MSC, we used
the MTT assay to quantify mitochondrial enzy-
matic activity; 3000 MSC per well were seeded
in  a  96-well  plate  (coated  with  laminin-5,
laminin-1, type I collagen or plastic as control)
for 24 h and the activity of mitochondrial reduc-
tase was quantified as described by the supplier
by measuring the absorbance of the produced
agent at ʻ=450 nm and ʻ=620 nm after 2.5 h of
incubation using the ELISA reader (EL800, Bio
Tek, Bad Friedrichshall, Germany).
BrdU cell proliferation assay
For further measurement of a possible time-
dependent proliferation of MSC we used the
BrdU  assay  quantifying  DNA  synthesis  after
three, seven, 16 and 24 h of incubation (BrdU-
Kit I (Roche). Three thousand MSC per well
were seeded in a 96-well plate (coated with
laminin-5, laminin-1, type I collagen or plastic
as control), 10 mmol 5-bromo-2’-deoxy-uridine
(BrdU) were added. Analysis of incorporated
BrdU was performed with anti-BrdU antibod-
ies which were then linked with anti-mouse
IgG  fluorescein.  Counterstaining  was  per-
formed with DAPI and visualized using a fluo-
rescence microscope (DM IRBE, Leica).
Osteogenic differentiation and von
Kossa stain
To explore osteogenic differentiation of the
cells, MSC of 10 different patients were seeded
at 5ﾥ104 cells/2 mL/well (coated with 5 mL of 1
mg/mL laminin-5, laminin-1, type I collagen or
plastic as control) in 6-well plates. MSC in star-
vation medium and in non-coated plates/flasks
served  as  controls.  After  four  days  of  MSC
expansion,  growth  medium  was  replaced  by
osteogenic  induction  medium  consisting  of
high glucose DMEM, FCS 10%, 0.1 mM dexam-
ethason, 10 nM ʲ-glycerolphosphate, 0.17 mM
L-ascorbic  acid,  100  U/mL  penicillin  G,  100
mg/mL streptomycin and fungicides. Progress of
osteogenic differentiation was analyzed at vari-
ous time points after three, seven and 28 days of
differentiation.  The  cultures  were  stained
according to the von Kossa staining protocol to
quantify  mineralization.  The  plates  were
scanned and images were analyzed for staining
density (Image J, NIH, USA). The level of con-
fluent  blackness  was  given  as  a  number
between 0 and 200, with 0 being black and 200
being white. For visualization, reciprocal value
was calculated and normalized to the control. 
Analysis of osteogenic marker
genes
RNA was isolated from cells after osteogenic
differentiation  for  three,  seven  or  14  days
(RNesay-Mini Kit, Qiagen, Hilden, Germany).
Cells were detached and the pellets disrupted
in  RLT  buffer  (1%  ʲ-mercaptoethanol)  and
RNA was isolated following the manufacturer’s
protocol. Reverse transcription of the RNA into
cDNA was achieved with 1 mg RNA using a
cDNA synthesis kit (Clontech, Mountain View
CA, USA). Gene-specific cDNA was amplified
by quantitative PCR (LightCycler 1.5, Roche),
each according to the manufactorer’s protocol.
Primer pairs for alkaline phosphatase (MWG,
Ebersberg, Germany), osteopontin, osteocalcin
(LCSearch,  Heidelberg,  Germany,  sequences
not published) and runt-related transcription
factor 2 (Runx-2, MWG) were used. The used
primer sequences were:
AP:
up 5’- ATT ACC TGG ACA TCG GCA AC -3’
down 5’- TTG GGC ACC ACA TCA TAG AA -3’
Runx-2:
up 5’- TCT GGC CTT CCA CTC TCA GT -3’
down 5’- GAC TGG CGG GGT GTA AGT AA -3’
In each PCR, GAPDH served as housekeep-
ing reference gene as described.17 To quantify
the RNA synthesis the number of RNA copies
was divided by the number of GAPDH copies.
All gene analyzes were performed on three cul-
tures of MSC and repeated twice.
Statistical analysis
Representative  data  were  presented  as
mean  values.  Statistical  analyses  were  per-
formed using ANOVA. P<0.05 was considered
significant.
Results
Expansion of mesenchymal stromal
cells
MSC were expanded to the second or third
passage. The cells presented as fibroblast-like
adherent and proliferating cells (Figure 1). All
populations (n=14) were characterized by flow
cytometry revealing expression of CD73, CD90
and  CD105  and  the  absence  or  minimal
expression of CD14, CD34 and CD45 (data not
shown). The proliferation capacity of MSC in
GMP-conforming media was high with an aver-
age time of 10.6 days till expansion into the
next passage (passage doubling time).
Attachment assay
Adhesion  was  measured  by  incubation  of
MSC  in  protein-coated  tissue  culture  plates
using cultures of MSC of 9 patients. Coated
bovine  serum  albumin  served  as  blocking
agent and as negative control. The assay was
performed with protein amounts of 1, 5, 100
Article
Figure  1.  Mesenchymal  stromal  cells  cul-
tured in animal serum-free media in passage
2  after  three  (A)  and  nine  (B)  days  with
increasing  confluence.  After  10-11  days,
cells were transferred to the next passage. 
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and 500 fmol/mL per spot. A protein amount of
5 fmol/mL was the lower limit for attachment to
type I collagen and laminin-5, although some
MSC attached to spots of 1 fmol/mL type I colla-
gen. Visualization of adherent MSC revealed
type I collagen to be most effective, followed by
laminin-5 and laminin-1 (Figure 2). 
MTT and BrdU assays
MTT assay was performed using cultures of
MSC of 8 patients. Cells of all cultures were
vital without showing significant differences
between  the  proteins  used  for  coating.
Growth  on  cell  culture  plastic  (control)
revealed  the  same  cell  viability  index  and
metabolic  activity  (average  extinction  rate
0.39-0.43; data not shown) compared to the
protein-coated samples.
BrdU assay was performed using cultures of
9 patients. MSC were expanded on protein-coat-
ed 96-well plates and BrdU-incorporation was
measured after three, seven, 16 und 24 h. On
average, 73% of MSC of laminin-5 coated wells
proliferated after 24 h, compared to type I colla-
gen  with  70%  followed  by  plastic  (67%)  and
laminin-1 (63%). Differences did not reach sta-
tistical significance. After three, seven and 16 h,
differences between proteins and plastic were
negligible: for example, average proliferation of
MSC on laminin-5 coated plates was 25% (3 h),
42% (7 h) and 51% (16 h). 
Osteogenic differentiation, von
Kossa stain, and analysis of
osteogenic marker genes
MSC  were  expanded  on  protein-coated
plates  (for  von  Kossa  stain)  or  in  protein-
coated cell culture flasks (for transcript analy-
sis of marker genes) with osteogenic differ-
entiation medium for three, seven, 14 and 28
days. Osteogenic differentiation of the MSC
was analyzed using von Kossa stain. Plates
were  evaluated  macroscopically  and  also
scanned to explore the degree of mineraliza-
tion  indicated  by  black  silver  precipitates.
Compared to plastic after 28 days of culture,
laminin-5 coated plates contained significant
more  calcium-phosphate  granula  (P<0.04),
followed by laminin-1 (P<0.09) and type I col-
lagen (Figure 3). No spontaneous osteogenic
differentiation of MSC in starvation medium
was observed.
To analyze osteogenic differentiation capac-
ity,  osteogenic  marker  genes  alkaline  phos-
phatase, osteopontin, osteocalcin and Runx-2
were investigated on 3 cultures. All four genes
were  expressed  whereas  analysis  of  gene
expression patterns did not reveal significant
differences between MSC cultured in coated
flasks  and  the  uncoated  control  after  three,
seven and 14 days (data not shown).
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Figure 2. Representative compilation of attachment of mesenchymal stromal cells on
plates coated with proteins (solution of 1 mL) of different concentrations. BSA (bovine
serum albumin) served as control. Mesenchymal stromal cells preferentially bound to type
I collagen and laminin-5 at a minimal concentration of 1-5 fmol/mL. 
Figure 3. Von Kossa stain (A) and measurement of blackness of silver precipitates (B) after
growth  of  mesenchymal  stromal  cells  on  plates  coated  with  different  proteins  and
osteogenic induction medium after three, seven and 28 days. Laminin-5 induced the
greatest production of calcium granula with significant differences compared to plastic
after 28 days (P<0.04). 
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Discussion
Cells expanded for clinical applications have
to meet the quality standards set by the health
authorities (e.g. EMA, FDA). We, therefore, iso-
lated and expanded MSC with animal serum-
free  medium  (FFPP:  fresh  frozen  plasma
platelet)  meeting  current  GMP-regulations.13
Due to different donors and preparation tech-
niques, the amounts and the composition of
growth  factors  varies  within  the  plasma
employed here.18 For that reason, serum sam-
ples from 15-25 individuals tested for growth
factor content and sera from suitable donors
were  then  pooled  and  stored  at  -70°C.13
Comparably, MSC vary considerably depending
on health and age of MSC donors, and depend
on  culture  conditions,  number  of  passages,
and other variables during in vitro expansion. 
MSC expanded in FFPP medium showed a
high  proliferation  capacity  and  fulfilled  the
minimal criteria for MSC with expression of
CD 90, CD 73 and CD 105 and lack of CD 14, CD
34 and CD 4, as described in previous stud-
ies.13,14,19,20
By MTT and BrdU assays, MSC high prolifer-
ation  rates  were  confirmed,  but  without
detectable influences by the coating proteins
employed on the metabolic activity. This could
be due to the short time of exposure to the pro-
teins  (only  24  h).  Furthermore,  FFPP  media
activated higher proliferation of MSC compared
to standard media.15 Therefore, minor changes
in MSC proliferation facilitated by laminins or
collagen possibly remained below detection lev-
els. Alternatively, the cell cycle and mitochondr-
ial metabolism was not directly influenced by
ECM-proteins investigated in our study. In con-
trast, Lindner et al. found a higher proliferation
rate of MSC in the presence of ECM proteins
when they studied a longer proliferation period
compared to our study.21
Klees et al. revealed, that laminin-5 induces
adhesion, osteogenic gene expression and dif-
ferentiation of human MSC through an ERK-
dependent  pathway.5,7,22-24 In  their  experi-
ments, MSC were expanded in media contain-
ing FCS. Similar results are described for type
I collagen.4,25By using FFPP medium for cultur-
ing MSC, our study supports the previous find-
ings of increased binding of MSC to the ECM-
proteins type I collagen and laminin-5. In that
context, we have to consider that we used a
specific  amount  of  proteins  without  noting
their exact amount of binding sites, especially
when  comparing  different  proteins.
Concerning laminin-5, the ￿3 LG3-domain was
described to induce adhesion and osteogenic
differentiation of MSC.7 Isolated use of such
domains  (peptide  fragments)  would  possibly
increase binding strength to MSC and could be
part of further studies. 
Evaluation  of  von  Kossa  stain  was  per-
formed by scanning the plates and measuring
the  blackness  of  the  silver  precipitates.
Evaluating  the  amount  of  produced  calcium
granula is described as an alternative.7
Regarding  osteogenic  differentiation,  our
study  revealed  a  significant  advantage  of
laminin-5 compared to type I collagen-coated
or uncoated plastic growth after 28 days of cul-
ture  in  osteogenic  differentiation  medium,
which is consistent with previous studies.5,22
Laminin-1  also  promoted  osteogenesis.  But
this  did  not  reach  statistical  significance
(P<0.09). 
We  found  only  slight  differences  in  RNA
expressions  of  osteogenic  marker  genes  in
MSC after a few days of osteogenic induction
on  protein-coated  versus non-coated  dishes,
which  correlate  with  a  previous  study.6 One
explanation  would  be  the  small  number  of
observed  probes.  In  addition,  extraction  of
mRNA from mineralizing probes is technically
challenging. Therefore, progress in osteogenic
differentiation makes it increasingly difficult
to extract suitable mRNA for cDNA synthesis
and quantitative PCR analyses. Furthermore,
MSC from bone marrow are already primed for
bone repair. In contrast to, for example, MSC
from placenta, they express some genes asso-
ciated  with  osteogenesis  spontaneously  in
vitro. RNA analyses are very sensitive and we
revealed osteogenic differentiation stain even
in non-coated plates after 3 days. 
In  summary,  we  report  that  human  bone
marrow derived MSC proliferate well in animal
serum-free GMP-conforming media, attach to
type  I  collagen,  and  with  lower  affinity  to
laminin-5 and laminin-1. Osteogenic differen-
tiation of MSC is not promoted by type I colla-
gen, but by attachment to laminin-1 and more
so  by  laminin-5.  We  conclude  that  coating
orthopedic implants with type I collagen may
not  facilitate  regeneration  of  bony  defects,
despite its high affinity to MSC. Our data con-
firm that laminin-5 or laminin-5-derived pep-
tides serve better in bone repair, as this mate-
rial  promotes  both  firm  attachment  and
osteogenic differentiation of MSC.
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